{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:00:42Z","timestamp":1790229642395,"version":"4.1.0"},"reference-count":49,"publisher":"The Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,11,1]]},"DOI":"10.1210\/jc.2008-0461","type":"journal-article","created":{"date-parts":[[2008,8,26]],"date-time":"2008-08-26T20:44:41Z","timestamp":1219783481000},"page":"4299-4306","source":"Crossref","is-referenced-by-count":213,"title":["The Impact of Metformin, Oral Contraceptives, and Lifestyle Modification on Polycystic Ovary Syndrome in Obese Adolescent Women in Two Randomized, Placebo-Controlled Clinical Trials"],"prefix":"10.1210","volume":"93","author":[{"given":"Kathleen","family":"Hoeger","sequence":"first","affiliation":[{"name":"Departments of Obstetrics and Gynecology (K.H., L.Koc., D.S.G.), University of Rochester Medical Center, Rochester, New York 14642"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Davidson","sequence":"additional","affiliation":[{"name":"Psychiatry (K.D.), University of Rochester Medical Center, Rochester, New York 14642"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Kochman","sequence":"additional","affiliation":[{"name":"Departments of Obstetrics and Gynecology (K.H., L.Koc., D.S.G.), University of Rochester Medical Center, Rochester, New York 14642"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Cherry","sequence":"additional","affiliation":[{"name":"Cardiology (T.C., L.Kop.), University of Rochester Medical Center, Rochester, New York 14642"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Kopin","sequence":"additional","affiliation":[{"name":"Cardiology (T.C., L.Kop.), University of Rochester Medical Center, Rochester, New York 14642"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Guzick","sequence":"additional","affiliation":[{"name":"Departments of Obstetrics and Gynecology (K.H., L.Koc., D.S.G.), University of Rochester Medical Center, Rochester, New York 14642"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041114075815100_R1","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population.","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114075815100_R2","first-page":"286","article-title":"Development of polycystic ovary syndrome: involvement of genetic and environmental factors","author":"Franks","year":"2006","journal-title":"Int J Androl 29:278\u2013285; discussion,"},{"key":"key\n\t\t\t\t2019041114075815100_R3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1210\/jc.2007-1834","article-title":"Impact of obesity on the risk for polycystic ovary syndrome.","volume":"93","author":"Yildiz","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114075815100_R4","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.295.13.1549","article-title":"Prevalence of overweight and obesity in the United States, 1999\u20132004.","volume":"295","author":"Ogden","year":"2006","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041114075815100_R5","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1210\/jc.2006-2002","article-title":"Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls.","volume":"92","author":"McCartney","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114075815100_R6","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1210\/jc.2005-1852","article-title":"The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism.","volume":"91","author":"McCartney","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114075815100_R7","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1210\/jc.2005-0011","article-title":"Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.","volume":"90","author":"Meyer","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114075815100_R8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/ncpendmet0755","article-title":"Cardiometabolic features of polycystic ovary syndrome.","volume":"4","author":"Hoffman","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114075815100_R9","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/jc.2005-2430","article-title":"Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome.","volume":"91","author":"Lo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114075815100_R10","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1210\/jcem.87.2.8199","article-title":"Altered vascular function in young women with polycystic ovary syndrome.","volume":"87","author":"Kelly","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114075815100_R11","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.ATV.20.11.2414","article-title":"Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women.","volume":"20","author":"Talbott","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t2019041114075815100_R12","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome.","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041114075815100_R13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1385\/ENDO:30:1:45","article-title":"Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS.","volume":"30","author":"Teede","year":"2006","journal-title":"Endocrine"},{"key":"key\n\t\t\t\t2019041114075815100_R14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.atherosclerosis.2005.10.007","article-title":"Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives.","volume":"185","author":"Cussons","year":"2006","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t2019041114075815100_R15","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ecl.2005.04.012","article-title":"Oral contraceptives and the management of hyperandrogenism-polycystic ovary syndrome in adolescents.","volume":"34","author":"Hillard","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"key":"key\n\t\t\t\t2019041114075815100_R16","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1515\/JPEM.2005.18.8.761","article-title":"Randomized controlled trial evaluating response to metformin versus standard therapy in the treatment of adolescents with polycystic ovary syndrome.","volume":"18","author":"Allen","year":"2005","journal-title":"J Pediatr Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114075815100_R17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1749-6632.2000.tb06236.x","article-title":"Combined oral contraceptive treatment of adolescent girls with polycystic ovary syndrome. Lipid profile.","volume":"900","author":"Creatsas","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"key\n\t\t\t\t2019041114075815100_R18","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0015-0282(02)02993-X","article-title":"Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives.","volume":"77","author":"Mastorakos","year":"2002","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041114075815100_R19","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.fertnstert.2005.07.1306","article-title":"Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome.","volume":"85","author":"Mastorakos","year":"2006","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041114075815100_R20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2007-992931","article-title":"Oral contraceptives in polycystic ovary syndrome: risk-benefit assessment.","volume":"26","author":"Yildiz","year":"2008","journal-title":"Semin Reprod Med"},{"key":"key\n\t\t\t\t2019041114075815100_R21","first-page":"1470","article-title":"Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone.","volume":"84","author":"Huber-Buchholz","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114075815100_R22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1043-2760(02)00612-4","article-title":"The role of lifestyle modification in polycystic ovary syndrome.","volume":"13","author":"Norman","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114075815100_R23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.fertnstert.2004.02.104","article-title":"A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and\/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.","volume":"82","author":"Hoeger","year":"2004","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041114075815100_R24","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/oxfordjournals.humrep.a135772","article-title":"Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women.","volume":"10","author":"Clark","year":"1995","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t2019041114075815100_R25","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/humrep\/deg367","article-title":"Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet.","volume":"18","author":"Crosignani","year":"2003","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t2019041114075815100_R26","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archpedi.157.8.821","article-title":"Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988\u20131994.","volume":"157","author":"Cook","year":"2003","journal-title":"Arch Pediatr Adolesc Med"},{"key":"key\n\t\t\t\t2019041114075815100_R27","first-page":"242","article-title":"Obesity\u2014a critical issue in preventive cardiology: the Bogalusa Heart Study","author":"Berenson","year":"2005","journal-title":"Prev Cardiol 8:234\u2013241; quiz"},{"key":"key\n\t\t\t\t2019041114075815100_R28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/157339906777950651","article-title":"Metformin beyond diabetes: new life for an old drug.","volume":"2","author":"Rotella","year":"2006","journal-title":"Curr Diabetes Rev"},{"key":"key\n\t\t\t\t2019041114075815100_R29","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bmj.327.7421.951","article-title":"Metformin in polycystic ovary syndrome: systematic review and meta-analysis.","volume":"327","author":"Lord","year":"2003","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019041114075815100_R30","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome.","volume":"356","author":"Legro","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114075815100_R31","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1210\/jcem.87.2.8261","article-title":"Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind, placebo controlled fashion.","volume":"87","author":"Fleming","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114075815100_R32","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1210\/jcem.86.10.7904","article-title":"Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy.","volume":"86","author":"Diamanti-Kandarakis","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114075815100_R33","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/01.CIR.92.6.1430","article-title":"Combined effects of HDL cholesterol, triglyceride, and total cholesterol concentrations on 18-year risk of atherosclerotic disease.","volume":"92","author":"Burchfiel","year":"1995","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041114075815100_R34","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1182\/blood.V71.1.220.bloodjournal711220","article-title":"Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay.","volume":"71","author":"Declerck","year":"1988","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019041114075815100_R35","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1515\/JPEM.2004.17.5.705","article-title":"Which treatment options should be used in adolescents with polycystic ovary syndrome?","volume":"17","author":"Villa","year":"2004","journal-title":"J Pediatr Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114075815100_R36","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/jama.286.12.1427","volume":"286","author":"Ludwig","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041114075815100_R37","doi-asserted-by":"crossref","first-page":"458","DOI":"10.5694\/j.1326-5377.2007.tb00997.x","article-title":"Overweight and obesity from childhood to adulthood: a follow-up of participants in the 1985 Australian Schools Health and Fitness Survey.","volume":"186","author":"Venn","year":"2007","journal-title":"Med J Aust"},{"key":"key\n\t\t\t\t2019041114075815100_R38","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1056\/NEJMsa073166","article-title":"Adolescent overweight and future adult coronary heart disease.","volume":"357","author":"Bibbins-Domingo","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114075815100_R39","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/EDE.0b013e3181257158","article-title":"Body mass index in adolescence and number of children in adulthood.","volume":"18","author":"Jokela","year":"2007","journal-title":"Epidemiology"},{"key":"key\n\t\t\t\t2019041114075815100_R40","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1210\/jc.2003-031281","article-title":"Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.","volume":"89","author":"Ibanez","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114075815100_R41","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/AOG.0b013e31816a2476","article-title":"Effects of third-generation oral contraceptives on high-sensitivity C-reactive protein and homocysteine in young women.","volume":"111","author":"Cauci","year":"2008","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t2019041114075815100_R42","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jama.281.4.335","article-title":"Effects of lifestyle activity vs structured aerobic exercise in obese women: a randomized trial.","volume":"281","author":"Andersen","year":"1999","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041114075815100_R43","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.beem.2006.03.008","article-title":"Role of lifestyle modification in the management of polycystic ovary syndrome.","volume":"20","author":"Hoeger","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114075815100_R44","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","article-title":"Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome.","volume":"36","author":"Kiddy","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041114075815100_R45","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05488","article-title":"Abdominal obesity and metabolic syndrome.","volume":"444","author":"Despres","year":"2006","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019041114075815100_R46","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.2337\/db07-0009","article-title":"Body size and shape changes and the risk of diabetes in the diabetes prevention program.","volume":"56","author":"Fujimoto","year":"2007","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041114075815100_R47","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.annepidem.2005.01.005","article-title":"A comparison of lipid variables as predictors of cardiovascular disease in the Asia Pacific region.","volume":"15","author":"Barzi","year":"2005","journal-title":"Ann Epidemiol"},{"key":"key\n\t\t\t\t2019041114075815100_R48","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1161\/01.CIR.96.8.2520","article-title":"Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction.","volume":"96","author":"Gaziano","year":"1997","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041114075815100_R49","article-title":"The triglyceride\/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors","author":"Quijada","journal-title":"Pediatr Diabetes"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/93\/11\/4299\/9053437\/jcem4299.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T19:15:57Z","timestamp":1588878957000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/93\/11\/4299\/2627248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,1]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2008-0461","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,1]]}}}